Cargando…
Beneficial health effects of Menaquinone‐7 on body composition, glycemic indices, lipid profile, and endocrine markers in polycystic ovary syndrome patients
OBJECTIVE: The aim of this study was to investigate the effect of oral vitamin K2 (Menaquinone‐7 [MK‐7]) on clinical and biochemical parameters in polycystic ovary syndrome (PCOS) patients. METHODS: In this randomized, double‐blind, placebo‐controlled clinical trial, 84 PCOS patients were randomly a...
Autores principales: | Tarkesh, Firoozeh, Namavar Jahromi, Bahia, Hejazi, Najmeh, Tabatabaee, Hamidreza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590292/ https://www.ncbi.nlm.nih.gov/pubmed/33133563 http://dx.doi.org/10.1002/fsn3.1837 |
Ejemplares similares
-
Effect of vitamin K2 administration on depression status in patients with polycystic ovary syndrome: a randomized clinical trial
por: Tarkesh, Firoozeh, et al.
Publicado: (2022) -
Glutathione-dependent enzymes in the follicular fluid of the first-retrieved oocyte and their impact on oocyte and embryos in polycystic ovary syndrome: A cross-sectional study
por: Zal, Fatemeh, et al.
Publicado: (2020) -
Associations of insulin resistance, sex hormone-binding globulin, triglyceride, and hormonal profiles in polycystic ovary syndrome: A cross-sectional study
por: Jahromi, Bahia Namavar, et al.
Publicado: (2021) -
Endocrine Disruptors and Polycystic Ovary Syndrome: Phthalates
por: Akın, Leyla, et al.
Publicado: (2020) -
Interactions of Truncated Menaquinones in Lipid Monolayers and Bilayers
por: Van Cleave, Cameron, et al.
Publicado: (2021)